GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
1-Year Est. Return 70.11%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+70.11%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$276M
AUM Growth
-$11.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
70
New
Increased
Reduced
Closed

Top Buys

1
+$14.7M
2
+$9.93M
3
+$8.99M
4
JANX icon
Janux Therapeutics
JANX
+$6.09M
5
DYN icon
Dyne Therapeutics
DYN
+$3.98M

Top Sells

1
+$19.1M
2
+$8.38M
3
+$8.04M
4
SLNO icon
Soleno Therapeutics
SLNO
+$7.18M
5
PCVX icon
Vaxcyte
PCVX
+$6.31M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRYS icon
51
Krystal Biotech
KRYS
$8.06B
– –
-8,500
RAPT icon
52
RAPT Therapeutics
RAPT
$1.68B
– –
0
SGMT icon
53
Sagimet Biosciences
SGMT
$186M
– –
-225,000
WVE icon
54
Wave Life Sciences
WVE
$2.59B
– –
-200,000
XBI icon
55
State Street SPDR S&P Biotech ETF
XBI
$8.13B
– –
0
MGNX icon
56
MacroGenics
MGNX
$126M
– –
-150,000
NTLA icon
57
Intellia Therapeutics
NTLA
$1.6B
– –
-25,000
PMVP icon
58
PMV Pharmaceuticals
PMVP
$90.5M
– –
-375,000
PTCT icon
59
PTC Therapeutics
PTCT
$5.47B
– –
-19,000
ACAD icon
60
Acadia Pharmaceuticals
ACAD
$4.16B
– –
-225,000
ALNY icon
61
Alnylam Pharmaceuticals
ALNY
$44.2B
– –
-22,500
ANTX icon
62
AN2 Therapeutics
ANTX
$30.1M
– –
-219,331
ARWR icon
63
Arrowhead Research
ARWR
$8.86B
– –
-35,000
BHVN icon
64
Biohaven
BHVN
$1.53B
– –
-490,000
CABA icon
65
Cabaletta Bio
CABA
$320M
– –
-370,899
CTMX icon
66
CytomX Therapeutics
CTMX
$910M
– –
-300,000
CYTK icon
67
Cytokinetics
CYTK
$7.61B
– –
-33,200
ELEV
68
DELISTED
Elevation Oncology
ELEV
– –
-600,000
ITCI
69
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-10,000
RVNC
70
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-225,000
1 2
3